XML 71 R47.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Commitments and Contingencies (Details Textual) - USD ($)
$ in Thousands
12 Months Ended
Mar. 14, 2017
Dec. 31, 2016
Feb. 02, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Operating Leases, Rent Expense, Net       $ 136 $ 33 $ 12
Wanchun Biotech [Member]            
Quarterly Royalty Payments Required As a Percentage of Gross Proceeds on Sale of Product   20.00%   20.00%    
Term of Royalty Payments   10 years        
Wanchun Biotech and Fortis Advisors LLC [Member]            
Period Following Royalty Termination Agreement, Requirement to Issue Shares     3 years      
Percentage of Fully-diluted Equity Capitalization Required to Be Issued As Shares in Lieu of Royalty Payments     10.00%      
Nereus Trust [Member] | Private Placement [Member] | Subsequent Event [Member]            
Stock Issued in Lieu of Royalty Payments 2,112,963